Cambridge, MA, United States of America

Muriel David

This inventor holds 1 USPTO granted patent. Top assignee: Hifibio (Hk) Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muriel David. Retrieved from https://idiyas.com/inventor/muriel-david

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muriel David: Innovator in Antibody Research

Introduction

Muriel David is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work is crucial in advancing medical research and therapeutic applications.

Latest Patents

Muriel David holds a patent for an "ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF." This innovative patent highlights her expertise in antibody development and its potential applications in treating various diseases.

Career Highlights

Muriel is currently associated with Hifibio (HK) Limited, where she continues to push the boundaries of scientific research. Her dedication to innovation has positioned her as a key player in the biotechnology sector.

Collaborations

Throughout her career, Muriel has collaborated with talented individuals such as Rachel Pacherie and Liang Schweizer. These partnerships have fostered a dynamic research environment, leading to groundbreaking discoveries.

Conclusion

Muriel David's contributions to antibody research exemplify her commitment to innovation in biotechnology. Her work not only enhances our understanding of antibodies but also paves the way for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…